ANN ARBOR STAGE III GRADE 2 FOLLICULAR LYMPHOMA
Clinical trials for ANN ARBOR STAGE III GRADE 2 FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE III GRADE 2 FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE III GRADE 2 FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise for Hard-to-Treat lymphoma
Disease control OngoingThis study tests a new drug combination (ALX148, rituximab, and lenalidomide) in people with B-cell non-Hodgkin lymphoma that has not responded to prior treatment. The goal is to find the best dose and see if the combo can shrink or control the cancer. About 47 adults with variou…
Matched conditions: ANN ARBOR STAGE III GRADE 2 FOLLICULAR LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Tiny radiation dose may tame eye lymphoma with fewer side effects
Disease control OngoingThis study tests whether an ultra low dose of radiation (4 Gy) can safely control slow-growing B-cell lymphoma or mantle cell lymphoma that has spread to the eye socket. About 50 adults with stage I to IV disease will receive this targeted radiation. The goal is to shrink or stop…
Matched conditions: ANN ARBOR STAGE III GRADE 2 FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC